What is the recommended titration schedule to increase gabapentin (Neurontin) from 300 mg at bedtime?

Gabapentin Dose Titration from 300mg at Bedtime

Increase gabapentin by 100-300 mg every 1-7 days as tolerated, starting with an additional 300 mg dose to reach 300 mg twice daily, then progressing to three times daily dosing. 1

Recommended Titration Schedule

Standard Titration Approach

The FDA-approved dosing for neuropathic pain conditions provides the clearest guidance 2:

• Current dose: 300 mg at bedtime
• Day 1-2: Add 300 mg in the morning → 300 mg twice daily (600 mg/day total)
• Day 3: Add third dose → 300 mg three times daily (900 mg/day total)
• Subsequent titration: Increase by 300 mg increments every 1-7 days based on tolerability and response 1

Target Dosing

For neuropathic pain conditions (postherpetic neuralgia, diabetic neuropathy):

• Effective dose range: 1800-3600 mg/day in three divided doses 2
• Minimum therapeutic dose: 900 mg/day 3
• Optimal dose: 1800 mg/day provides good efficacy-tolerability balance 3
• Maximum dose: 3600 mg/day (doses above 1800 mg/day show comparable effects but no consistently superior benefit) 2

For epilepsy (patients >12 years):

• Effective dose range: 900-1800 mg/day in three divided doses 2
• Well-tolerated doses: Up to 2400 mg/day in long-term studies 2

Key Titration Principles

Timing Between Doses

• Maximum interval: 12 hours between doses in three-times-daily schedule 2
• This prevents subtherapeutic troughs due to gabapentin's nonlinear pharmacokinetics 1

Rapid vs. Slow Titration

Evidence supports flexibility in titration speed 3, 4:

• Rapid initiation: Starting at 900 mg/day (300 mg TID immediately) is well-tolerated, with only slightly higher dizziness rates 4
• Standard approach: 300 mg day 1,600 mg day 2,900 mg day 3 remains the FDA-recommended schedule 2
• Slower titration: Increases by 100-300 mg every 1-7 days may reduce dose-dependent dizziness and sedation 1

Critical Caveats and Adjustments

Renal Impairment

Mandatory dose adjustment based on creatinine clearance 2:

• CrCl ≥60 mL/min: Standard dosing (900-3600 mg/day)
• CrCl 30-59 mL/min: 400-1400 mg/day in divided doses
• CrCl 15-29 mL/min: 200-700 mg/day, once daily dosing
• CrCl <15 mL/min: 100-300 mg/day, once daily dosing
• Hemodialysis: Supplemental post-dialysis doses required 2

Geriatric Patients

• Lower starting doses and slower titration recommended due to age-related decline in renal function 1
• Dose selection should be based on creatinine clearance values 2

Common Adverse Effects

Dose-dependent and typically transient 1, 3:

• Dizziness and somnolence are most common
• Usually subside within approximately 10 days from initiation 3
• Can be minimized by starting with lower doses and cautious titration 1

Duration of Adequate Trial

Allow sufficient time to assess efficacy 1:

• Neuropathic pain: 3-8 weeks for titration plus 2 weeks at maximum tolerated dose
• Total trial duration: Can require 2 months or more for adequate assessment 1
• Optimal seizure control in epilepsy may take months to achieve 5

Practical Algorithm

1. Assess renal function before any dose increase 2
2. From 300 mg qhs: Add morning dose of 300 mg (now 300 mg BID)
3. After 1-7 days: Add midday dose of 300 mg (now 300 mg TID = 900 mg/day)
4. Continue titration: Increase by 300 mg every 1-7 days as tolerated
5. Target 1800 mg/day (600 mg TID) for most neuropathic pain conditions 3
6. Consider up to 3600 mg/day if inadequate response at 1800 mg/day and well-tolerated 2
7. Maintain at maximum tolerated dose for 2 weeks before declaring treatment failure 1